Vanloese, Denmark

Ann Fullerton

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pharmacia & Upjohn Ab. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Fullerton. Retrieved from https://idiyas.com/inventor/ann-fullerton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Ann Fullerton

Introduction

Ann Fullerton is a noteworthy inventor based in Vanlose, Denmark. With a focus on pharmaceutical innovations, she has significantly contributed to the field of drug delivery systems. Her pioneering work has led to the development of solutions that enhance the effectiveness of medications.

Latest Patents

Ann holds a patent for her innovative work titled "Topical compositions for transdermal delivery of prodrug derivatives." This patent highlights her expertise in creating formulations that improve the absorption and efficacy of therapeutic agents through the skin.

Career Highlights

Throughout her career, Ann has been associated with Pharmacia & Upjohn A.B., a company renowned for its commitment to advancing healthcare through science and innovation. Her contributions to the field have positioned her as a valuable asset in pharmaceutical research and development.

Collaborations

In her journey, Ann has collaborated with esteemed colleagues such as Hans Bundgaard and Lona Christrup. Their collective efforts have fostered advancements in drug delivery technologies and exemplify the importance of teamwork in scientific research.

Conclusion

Ann Fullerton's dedication to innovation in pharmaceuticals is evident in her patent and collaborations. Her work is a testament to the impact inventors can have on improving healthcare and enhancing the lives of patients through effective treatment solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…